IGF1 and stroke disorder: In parallel, insulin‐like growth factor binding protein‐3 (IGFBP‐3) modulates the bioavailability, transportation, and localization of insulin‐like growth factor‐I (IGF‐I), in animal stroke models especially when administered intranasally (Liu et al., 2001).